These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Plasma exchange with a membrane filter in glomerulonephritis mediated by antibodies to glomerular basement membrane. Krediet RT; Balk AG; Egberts G; Arisz L Neth J Med; 1982; 25(8):255-61. PubMed ID: 7144992 [No Abstract] [Full Text] [Related]
4. [History of nephrology in the last 100 years: Acute rapidly progressive glomerulonephritis]. Koyama A; Hirayama K Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1479-83. PubMed ID: 12082738 [No Abstract] [Full Text] [Related]
5. Crescentic glomerulonephritis--which patients should be treated with plasma exchange? Bell GM; Cumming AD; Swainson CP; Winney RJ; Robson JS Life Support Syst; 1983; 1 Suppl 1():92-4. PubMed ID: 6336470 [No Abstract] [Full Text] [Related]
6. Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis. Pusey CD; Lockwood CM Prog Clin Biol Res; 1982; 106():91-104. PubMed ID: 6757955 [No Abstract] [Full Text] [Related]
7. Idiopathic rapidly progressive glomerulonephritis. Couser WG Am J Nephrol; 1982; 2(2):57-69. PubMed ID: 6758582 [No Abstract] [Full Text] [Related]
11. Animal model of human disease: anti-glomerular-basement-membrane glomerulonephritis. Steblay RW Am J Pathol; 1979 Sep; 96(3):875-8. PubMed ID: 474722 [No Abstract] [Full Text] [Related]
12. Efficacy of plasma exchange in severe idiopathic rapidly progressive glomerulonephritis. A report of ten cases. Burran WP; Avasthi P; Smith KJ; Simon TL Transfusion; 1986; 26(4):382-7. PubMed ID: 3727013 [TBL] [Abstract][Full Text] [Related]
13. [Various types of glomerulonephritis. Rapidly progressive glomerulonephritis]. Sakai O; Yoshida H Nihon Rinsho; 1988 Jun; 46(6):1279-84. PubMed ID: 3418895 [No Abstract] [Full Text] [Related]
14. [The value of cellular immune reactions in rapidly progressive glomerulonephritis]. Igelmann HJ; Intorp HW; Gruber H; Losse H Verh Dtsch Ges Inn Med; 1978; (84):1333-7. PubMed ID: 741958 [No Abstract] [Full Text] [Related]
15. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Hind CR; Paraskevakou H; Lockwood CM; Evans DJ; Peters DK; Rees AJ Lancet; 1983 Feb; 1(8319):263-5. PubMed ID: 6130293 [TBL] [Abstract][Full Text] [Related]
16. Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. Klassen J; Elwood C; Grossberg AL; Milgrom F; Montes M; Sepulveda M; Andres GA N Engl J Med; 1974 Jun; 290(24):1340-4. PubMed ID: 4275110 [No Abstract] [Full Text] [Related]
17. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis. Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229 [No Abstract] [Full Text] [Related]
18. [Rapidly progressing glomerulonephritis with antibodies to glomerular capillary basement membrane]. Matousovic K; Rossmann P Cas Lek Cesk; 1993 Mar; 132(6):174-7. PubMed ID: 8485756 [TBL] [Abstract][Full Text] [Related]
19. An overlapping etiology of rapidly progressive glomerulonephritis. Markowitz GS; Radhakrishnan J; D'Agati VD Am J Kidney Dis; 2004 Feb; 43(2):388-93. PubMed ID: 14750107 [No Abstract] [Full Text] [Related]
20. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Pusey CD; Lockwood CM; Peters DK Int J Artif Organs; 1983 Jul; 6 Suppl 1():15-8. PubMed ID: 6642729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]